Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Testing effectiveness (Phase 2)Ended earlyNCT00948688
What this trial is testing

Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 10
Not applicableEnded earlyNCT00660348
What this trial is testing

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
PainPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Study completedNCT03410914
What this trial is testing

Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy

Who this might be right for
Pancreas CancerPancreas DiseasePancreas Adenocarcinoma+4 more
Sunnybrook Health Sciences Centre 52
Testing effectiveness (Phase 2)UnknownNCT02528526
What this trial is testing

Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm

Who this might be right for
Pancreatic NeoplasmsHepatocellular CancerCholangiocarcinoma+1 more
University of Zurich 69
Large-scale testing (Phase 3)Study completedNCT00058149
What this trial is testing

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00003426
What this trial is testing

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00331682
What this trial is testing

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 10
Early research (Phase 1)Looking for participantsNCT07630961
What this trial is testing

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more
Novartis Pharmaceuticals 66
Early research (Phase 1)Looking for participantsNCT04150042
What this trial is testing

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Who this might be right for
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
General Oncology, Inc. 24
Not applicableEnrolling By InvitationNCT06967662
What this trial is testing

Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Ilyinskaya Hospital, JSC 28
Not applicableLooking for participantsNCT05714124
What this trial is testing

Liver Embolization Approaches for Tumor Management

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaMetastatic Colon Cancer+4 more
IRCCS San Raffaele 580
Not applicableActive Not RecruitingNCT02757859
What this trial is testing

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 845
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Testing effectiveness (Phase 2)Looking for participantsNCT05116072
What this trial is testing

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the DuodenumAmpullary Adenocarcinoma
University Hospital, Lille 36
Early research (Phase 1)Study completedNCT04990037
What this trial is testing

The Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Cantargia AB 25
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07303465
What this trial is testing

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
KRAS G12D MutationsPancreatic Ductal Adenocarcinoma (PDAC)
Ranok Therapeutics (Hangzhou) Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01146054
What this trial is testing

Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Stanford University 59
Not applicableStudy completedNCT02310230
What this trial is testing

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

Who this might be right for
Biliary Tract DiseasesStomach NeoplasmsCarcinoma, Pancreatic Ductal+1 more
Donald Mathews 100
Next Page